+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy?



Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy?



Transfusion Medicine and HemoTherapy 43(4): 256-267



Mesenchymal stem/stromal cells (MSCs) are becoming increasingly important for the development of cell therapeutics in regenerative medicine. Featuring immunomodulatory potential as well as secreting a variety of trophic factors, MSCs showed remarkable therapeutic effects in numerous preclinical disease models. However, sustainable translation of MSC therapies to the clinic is hampered by heterogeneity of MSCs and non-standardized in vitro culture technologies. Moreover, potent MSC therapeutics require MSCs with maximum regenerative capacity. There is growing evidence that in vitro preconditioning strategies of MSCs can optimize their therapeutic potential. In the following we will discuss achievements and challenges of the development of MSC therapies in regenerative medicine highlighting specific in vitro preconditioning strategies prior to cell transplantation to increase their therapeutic efficacy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058294918

Download citation: RISBibTeXText

PMID: 27721701

DOI: 10.1159/000447458


Related references

Secretome of mesenchymal stem/stromal cells in regenerative medicine. Biochimie 95(12): 2195, 2013

Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering. Stem Cells International 2018: 8031718, 2018

Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Past, Present, and Future. Cellular Reprogramming 19(4): 217-224, 2017

The extracellular vesicles-derived from mesenchymal stromal cells: A new therapeutic option in regenerative medicine. Journal of Cellular Biochemistry 119(10): 8048-8073, 2018

Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential. Plos one 9(3): E90667, 2014

Aging of bone marrow mesenchymal stromal/stem cells: Implications on autologous regenerative medicine. Bio-Medical Materials and Engineering 28(S1): S57-S63, 2017

Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells International 2013: 496218, 2013

Nonexpanded mesenchymal stem cells for regenerative medicine: yield in stromal vascular fraction from adipose tissues. Tissue Engineering. Part C Methods 16(6): 1515-1521, 2010

Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases. Stem Cell Research and Therapy 9(1): 45, 2018

Strategies in regenerative medicine for intervertebral disc repair using mesenchymal stem cells and bioscaffolds. Regenerative Medicine 11(7): 705-724, 2016

A Subset of Paracrine Factors as Efficient Biomarkers for Predicting Vascular Regenerative Efficacy of Mesenchymal Stromal/Stem Cells. Stem Cells 37(1): 77-88, 2019

Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine. International Journal of Molecular Sciences 18(9):, 2017

Mesenchymal stem cells secretome: a new therapeutic tool for Parkinsons disease regenerative medicine?. European Neuropsychopharmacology 27: S687-S688, 2017

Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic results. Panminerva Medica 52(1): 27-40, 2010

Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy. Cell Biology International 39(1): 23-34, 2015